Showing results (11-20 of 90) with videos related to
Sort By:
Pageof 9
Neuropharmacology|June 1, 1988
Anticonvulsant effects of a novel aminobenzamide (LY201116) in miceJ D Leander, R R Lawson, D W RobertsonPharmacology, Biochemistry, and Behavior|July 1, 1988
Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus releaseR W Fuller, H D Snoddy, D W RobertsonEuropean Journal of Pharmacology|July 4, 1989
Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortexD T Wong, D W Robertson, L R ReidResearch Communications in Chemical Pathology and Pharmacology|April 1, 1992
Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in ratsR W Fuller, H D Snoddy, D W RobertsonNaunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1989
Electrophysiological effects of flecainide enantiomers in canine Purkinje fibresJ K Smallwood, D W Robertson, M I SteinbergCirculation Research|July 1, 1989
Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranesR F Kauffman, B G Utterback, D W RobertsonNeuroscience Letters|July 23, 1993
Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sitesD R Gehlert, S L Gackenheimer, D W RobertsonNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1991
Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptorsD T Wong, P G Threlkeld, D W RobertsonCirculation Research|May 1, 1989
Specific binding of [3H]LY186126, an analogue of indolidan (LY195115), to cardiac membranes enriched in sarcoplasmic reticulum vesiclesR F Kauffman, B G Utterback, D W RobertsonResearch Communications in Chemical Pathology and Pharmacology|October 1, 1985
Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletorsR W Fuller, S K Hemrick-Luecke, D W RobertsonPageof 9